When You Notice Changes: A Molecular Approach to Understanding Cognitive Wellness Over Time
“Mom keeps forgetting where she put her keys.”
“Dad asked me the same question three times this morning.”
“Is this just normal aging, or should we be concerned?”
If you're noticing changes in a loved one's memory or thinking—or if you're experiencing changes yourself—you're not alone. These moments of uncertainty are deeply stressful for families, often leading to worry, confusion about what's normal, and questions about what steps to take.
CerebralScoreTM offers a different approach: research-informed molecular insights that can help you understand cognitive wellness patterns over time. It's not a diagnostic tool and it doesn't replace medical evaluation, but it provides objective data that many families find valuable as part of their broader wellness journey.
The Challenge of “Is This Normal?”
One of the most difficult aspects of noticing cognitive changes is the uncertainty. Everyone forgets things occasionally. Everyone has moments of confusion or misplaced words. But when do normal age-related changes cross into something that warrants attention?
The statistics highlight why this uncertainty is so common. Recent research estimates that 42% of Americans over age 55 will eventually develop dementia,1 and the proportion of adults ages 70 and older with dementia is approximately 10%.2 With dementia risk at 4% by age 75 and 20% by age 85,1 many families find themselves in this uncertain space, wondering whether changes they're observing are significant.
The challenge is that cognitive changes often happen gradually. What seems like a minor memory lapse today might become a pattern over months. Or it might remain stable and be nothing more than normal aging. Without objective data tracked over time, it's difficult to distinguish between these scenarios.
What CerebralScoreTM Offers
CerebralScoreTM is a saliva-based wellness test that analyzes 209 methylation patterns in cell-free DNA to generate an AI-driven cognitive wellness score. It's designed to provide molecular insights that can be tracked longitudinally—meaning you can see patterns and trends over time.
What it is:
- A wellness monitoring tool based on DNA methylation analysis
- A way to track molecular patterns over time with objective data
- A simple, at-home saliva test requiring no needles or invasive procedures
- Research-informed technology using the same molecular science as biological age testing
What it is not:
- A diagnostic test for Alzheimer's disease, dementia, or any medical condition
- A replacement for medical evaluation by healthcare providers
- A definitive answer about cognitive status or prognosis
- A standalone tool for medical decision-making
Think of CerebralScoreTM as one piece of information among many—a molecular data point that can be tracked over time and discussed with healthcare providers as part of a comprehensive approach to cognitive wellness.
The Science: Cell-Free DNA and Methylation Patterns
CerebralScoreTM uses a scientific approach called DNA methylation analysis. Here's what that means in plain language:
As cells throughout your body naturally die and renew themselves, they release tiny fragments of DNA into your bloodstream and saliva. These DNA fragments carry “methylation patterns”—chemical markers that act like molecular fingerprints, revealing information about where the DNA came from and the biological processes occurring in your body.
Circulating cell-free DNA is emerging as a valuable marker for wellness monitoring, offering genomic and epigenomic information that was previously difficult to access.3 Research has demonstrated that DNA methylation serves as a reliable identifier of cell type and biological state,4 and its stability makes it useful for tracking patterns over time.
Studies analyzing methylation differences between brain tissue and other samples have identified patterns that can distinguish between different cell types and their molecular signatures.5 This means a simple saliva sample can provide molecular insights that complement other information you and your healthcare providers are considering.
Why Tracking Patterns Over Time Matters
A single test result is a snapshot—a data point in time. The real value of wellness monitoring emerges when you track patterns longitudinally. Are methylation patterns remaining stable? Are they shifting gradually? How do changes in patterns correlate with other observations or lifestyle modifications?
Research in cognitively normal individuals and those with cognitive concerns identified differential methylation patterns across multiple DNA regions, with studies emphasizing that tracking complex methylation signatures over time provides more meaningful insights than single measurements.6
For families noticing changes, this longitudinal approach offers something valuable: objective molecular data that can be discussed with healthcare providers. Instead of relying solely on subjective observations (“I think Mom's memory is worse”), you have quantifiable information (“Here's how Mom's methylation patterns have changed over six months”).
This doesn't replace clinical assessment, but it adds a dimension of data that many families and their healthcare teams find helpful.
The 209-Marker Approach
CerebralScoreTM doesn't look at just one or two markers—it analyzes 209 different methylation sites across the DNA in your saliva sample. This comprehensive approach matters because cognitive wellness involves multiple molecular pathways and biological processes.
Consider this analogy: if you were trying to understand cardiovascular wellness, you wouldn't look at just one number. You'd want blood pressure, cholesterol (HDL and LDL), triglycerides, inflammatory markers, and more. The comprehensive picture tells you more than any single measurement.
The same principle applies to cognitive wellness monitoring. Research reinforces that complex methylation biosignatures, rather than individual sites, provide more meaningful patterns for tracking over time.6 CerebralScoreTM's 209-marker panel creates a comprehensive molecular profile—a wellness “fingerprint” that captures multiple dimensions.
When tracked over time—perhaps every 3–6 months—these patterns can reveal trends that might not be apparent from any single test.
Simple, At-Home Testing
- No needles required: The test uses a simple saliva sample. No blood draws, no invasive procedures, no discomfort.
- At-home collection: The kit arrives at your home. Collect the saliva sample, then mail it back in the prepaid envelope.
- No doctor's appointment needed: While we recommend working with healthcare providers, the test itself fits your timeline.
- Digital results: Results are delivered digitally, making them easy to save, share, and track over time.
Understanding Your Results
CerebralScoreTM provides an AI-generated cognitive wellness score based on the 209 methylation patterns analyzed in your sample. The score represents a comprehensive assessment of your methylation profile at that point in time.
Important context:
- This is wellness data, not medical diagnosis
- Scores should be interpreted over time, not as single data points
- Changes in scores don't necessarily indicate medical conditions
- Discuss results with healthcare providers as part of a comprehensive evaluation
The value lies in tracking your patterns over time. Establishing a baseline, then retesting every 3–6 months, allows you to see whether patterns are stable or changing. Many families share these results with physicians to complement clinical assessments.
When to Consider Testing
- You're noticing subtle changes: Memory lapses are more frequent, or daily function feels different.
- You want objective data: Add molecular data you can track over time and discuss with providers.
- You're in a waiting period: Use longitudinal wellness data to complement follow-up.
- You want to track patterns: See if lifestyle changes are reflected in methylation patterns.
- You have family history: Be proactive about wellness monitoring for yourself or loved ones.
- Between appointments: Fill the gaps with wellness data points between clinical visits.
The Lifestyle Connection
One reason families find value in wellness monitoring is that it can inform and motivate lifestyle interventions. Research consistently shows that certain lifestyle factors support cognitive wellness.
Studies demonstrate that exercise—both aerobic and resistance training, as well as mind-body practices—has shown efficacy for better cognitive outcomes.10 Recent clinical trials found that comprehensive lifestyle changes may significantly improve cognition and function in individuals with early cognitive concerns.11
- Regular physical exercise (aim for ~150 minutes weekly of moderate activity)
- A nutrient-rich diet emphasizing vegetables, fruits, whole grains, and omega-3s
- Quality sleep (7–9 hours nightly)
- Stress management (meditation, yoga, relaxation practices)
- Social engagement and mentally stimulating activities
- Manage cardiovascular risk factors (blood pressure, cholesterol, diabetes)
- Limit alcohol; avoid smoking
With CerebralScoreTM, families can see whether lifestyle efforts align with stable or improving methylation patterns—or whether changing patterns suggest it's time to consult providers about additional evaluation.
Supporting Your Loved One
- Frame it as wellness, not diagnosis: This is about understanding patterns over time.
- Highlight the simplicity: At-home saliva sample; no needles or appointments.
- Emphasize tracking: Value comes from multiple data points over months.
- Include them in decisions: Involve your loved one wherever possible.
- Connect to positive action: Use data to inform supportive lifestyle steps.
Working With Healthcare Providers
- Share results at appointments to complement clinical assessments.
- Use data to prompt conversations if patterns change meaningfully.
- Combine with clinical evaluation (cognitive testing, exam, appropriate diagnostics).
- Ask for interpretation in your specific clinical context.
- Don't self-diagnose: CerebralScoreTM is a wellness tool, not a diagnostic.
The Emotional Dimension
Noticing cognitive changes is emotionally difficult. For some, objective data reduces anxiety by replacing uncertainty with information; for others, it may increase worry. Consider whether having molecular data will help your family make informed decisions—and ensure results are used alongside medical guidance.
The Value of Early Awareness
Research consistently shows that interventions are most effective when implemented early. Elderly people with mild cognitive impairment are more likely to develop dementia than those without MCI, and targeted interventions can improve brain functioning.9
This doesn't mean that CerebralScoreTM detects MCI—it's a wellness test. But longitudinal molecular patterns can help inform when to have conversations with providers about comprehensive evaluation and proactive interventions.
Getting Started
- Order your kit: Visit the CerebralScoreTM website and order an at-home test kit
- Collect the sample: Follow simple instructions to collect a saliva sample at home
- Mail it back: Use the prepaid return envelope to send the sample to the lab
- Receive results: Get your AI-generated cognitive wellness score and methylation insights digitally
- Plan for follow-up: Consider retesting in 3–6 months to track patterns over time
- Share with providers: Bring results to appointments to discuss with your care team
A Tool, Not a Solution
CerebralScoreTM is one tool among many for understanding and supporting cognitive wellness. It doesn't replace medical evaluation, cognitive testing, or clinical judgment. Used alongside medical care, lifestyle optimization, and appropriate interventions, wellness monitoring can contribute to a comprehensive approach.
You're not alone in this journey. CerebralScoreTM is designed to be one part of a support system—providing research-informed molecular insights that complement other resources available to families navigating cognitive wellness concerns.
References
- Fang, M., et al. (2025). Lifetime risk and projected burden of dementia. Nature Medicine. https://www.nature.com/articles/s41591-024-03340-9
- Freedman, V. A., et al. (2024). Dementia Prevalence, Incidence, and Mortality Trends Among U.S. Adults Ages 72 and Older, 2011–2021. The Journals of Gerontology: Series A. https://academic.oup.com/biomedgerontology/article/79/Supplement_1/S22/7655435
- O'Hara, R., et al. (2024). Considering Biomarkers of Neurodegeneration in Alzheimer's Disease: The Potential of Circulating Cell-Free DNA in Precision Neurology. Journal of Personalized Medicine. https://www.mdpi.com/2075-4426/14/11/1104
- Jain, P., et al. (2023). Detection of neuron-derived cfDNA in blood plasma: a new diagnostic approach for neurodegenerative conditions. Frontiers in Neurology. https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2023.1272960/full
- Jain, P., et al. (2023). Detection of neuron-derived cfDNA in blood plasma: a new diagnostic approach for neurodegenerative conditions. Frontiers in Neurology. https://pmc.ncbi.nlm.nih.gov/articles/PMC10643874/
- O'Hara, R., et al. (2024). Considering Biomarkers of Neurodegeneration in Alzheimer's Disease: The Potential of Circulating Cell-Free DNA in Precision Neurology. Journal of Personalized Medicine. https://pmc.ncbi.nlm.nih.gov/articles/PMC11595805/
- Yang, S., et al. (2025). Whole-genome bisulfite sequencing of cell-free DNA unveils age-dependent and ALS-associated methylation alterations. Cell & Bioscience. https://cellandbioscience.biomedcentral.com/articles/10.1186/s13578-025-01366-1
- Zhang, Y., et al. (2024). Methylated cell-free DNA as a novel biomarker in Alzheimer's disease. Clinica Chimica Acta. https://www.sciencedirect.com/science/article/abs/pii/S0009898124023222
- Petersen, R. C. (2016). Mild Cognitive Impairment. CONTINUUM: Lifelong Learning in Neurology. https://pubmed.ncbi.nlm.nih.gov/27662909/
- Demurtas, J., et al. (2020). Physical Activity and Exercise in Mild Cognitive Impairment and Dementia: An Umbrella Review. Journal of the American Medical Directors Association. https://www.jamda.com/article/S1525-8610(20)30737-4/fulltext
- Ornish, D., et al. (2024). Intensive lifestyle changes in MCI or early dementia due to Alzheimer's disease: randomized, controlled trial. Alzheimer's Research & Therapy. https://alzres.biomedcentral.com/articles/10.1186/s13195-024-01482-z
- Lee, M., et al. (2022). Cell-free DNA methylation as a potential biomarker in brain disorders. Brain Sciences. https://pmc.ncbi.nlm.nih.gov/articles/PMC9066291/
- Sanchez-Mut, J. V., et al. (2016). Human DNA methylomes of neurodegenerative diseases show common epigenomic patterns. Translational Psychiatry. https://www.nature.com/articles/tp2015214